EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

A novel inhibitor of class IIa histone deacetylases attenuates collagen‐induced arthritis

Eunice K Poon iD, Ligong Liu, Kai-Chen Wu iD, Junxian Lim iD, Matthew J Sweet iD, Rink-Jan Lohman, Abishek Iyer, David P Fairlie iD

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.17306 ↗

At a glance

Journal article in British Journal of Pharmacology, 2024. Written by Eunice K Poon and 7 co-authors. Institution: Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia. Major MEDLINE topics: Arthritis, Experimental, Histone Deacetylase Inhibitors. Cited 4 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Health and Medical Research Council of Australia, Australian Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Most inhibitors of histone deacetylases (HDACs) are not selective and are cytotoxic. Some have anti‐inflammatory activity in disease models, but cytotoxicity prevents long‐term uses in non‐fatal diseases. Inhibitors selective for class IIa HDACs are much less cytotoxic and may have applications in management of chronic inflammatory diseases. Experimental Approach LL87 is a novel HDAC inhibitor examined here for HDAC enzyme selectivity. It was also investigated in macrophages for cytotoxicity and for inhibition of lipopolysaccharide (LPS)‐stimulated cytokine secretion. In a rat model of collagen‐induced arthritis, LL87 was investigated for effects on joint inflammation in Dark Agouti rats. Histological, immunohistochemical, micro‐computed tomography and molecular analyses characterise developing arthritis and anti‐inflammatory efficacy. Key Results LL87 was significantly more inhibitory against class IIa than class I or IIb HDAC enzymes. In macrophages, LL87 was not cytotoxic and reduced both LPS‐induced secretion of pro‐inflammatory cytokines, and IL6‐induced class IIa HDAC activity. In rats, LL87 attenuated paw swelling and clinical signs of arthritis, reducing collagen loss and histological damage in ankle joints. LL87 decreased immune cell infiltration, especially pro‐inflammatory macrophages and osteoclasts, into synovial joints and significantly reduced expression of pro‐inflammatory cytokines and tissue‐degrading proteases. Conclusion and Implications A novel inhibitor of class IIa HDACs has been shown to have an anti‐inflammatory and anti‐arthritic profile distinct from current therapies. It is efficacious in reducing macrophage infiltration and joint inflammation in a chronic model of rat arthritis.

Subjects

MeSH terms (MEDLINE)

Arthritis, ExperimentalHistone Deacetylase InhibitorsAnimalsRatsMaleAnti-Inflammatory AgentsMiceCytokinesMacrophagesHistone DeacetylasesLipopolysaccharides

Author keywords

arthritisclass IIa HDACcollagenmacrophageosteoclast

Substances

Histone Deacetylase InhibitorsAnti-Inflammatory AgentsCytokinesHistone DeacetylasesLipopolysaccharides

Authors and institutions

  • Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
  • Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, Queensland, Australia.

ORCID profiles: Eunice K Poon, Kai-Chen Wu, Junxian Lim, Matthew J Sweet, David P Fairlie

Funding

  • National Health and Medical Research Council of Australia
  • Australian Research Council

Cite

APA

Poon, E. K., Liu, L., Wu, K. C., Lim, J., Sweet, M. J., Lohman, R. J., Iyer, A., & Fairlie, D. P. (2024). A novel inhibitor of class IIa histone deacetylases attenuates collagen‐induced arthritis. British Journal of Pharmacology. https://doi.org/10.1111/bph.17306

Vancouver

Poon EK, Liu L, Wu KC, Lim J, Sweet MJ, Lohman RJ, et al. A novel inhibitor of class IIa histone deacetylases attenuates collagen‐induced arthritis. British Journal of Pharmacology. 2024. doi:10.1111/bph.17306

BibTeX
@article{Poon2024,
  author = {Poon, Eunice K and Liu, Ligong and Wu, Kai-Chen and Lim, Junxian and Sweet, Matthew J and Lohman, Rink-Jan and Iyer, Abishek and Fairlie, David P},
  title = {A novel inhibitor of class IIa histone deacetylases attenuates collagen‐induced arthritis},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.17306}
}
Start for free →